Sinclair Pharma PLC Director/PDMR Shareholding (4685P)

TIDMSPH

RNS Number : 4685P

Sinclair Pharma PLC

17 November 2016

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulations)

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------ 
 a.   Name                            Alan Olby 
---  ------------------------------  ---------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------ 
 a.   Position/status                 Chief Financial Officer 
---  ------------------------------  ---------------------------------- 
 b.   Initial notification            Initial Announcement 
       /Amendment 
---  ------------------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------ 
 a.   Name                            Sinclair Pharma plc 
---  ------------------------------  ---------------------------------- 
 b.   LEI 
---  ------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------ 
 a.   Description                     Ordinary Shares of 1 pence each 
       of the                          in Sinclair Pharma plc 
       Financial 
       instrument, 
       type 
       of instrument                   GB0033856740 
       Identification 
       code 
---  ------------------------------  ---------------------------------- 
 b.   Nature of 
       the transaction                  Exercise of Replacement Options 
---  ------------------------------  ---------------------------------- 
 c.   Price(s)                          Price(s)   Volume(s) 
       and volume(s)                    ---------  ---------- 
                                         28.5p      6,748 
                                        ---------  ---------- 
---  ------------------------------  ---------------------------------- 
 d.        Aggregated 
            information                            N/A 
             *    Aggregated volume 
 
 
             *    Price 
---  ------------------------------  ---------------------------------- 
 e.   Date of the                     2016-11-14 
       transaction 
---  ------------------------------  ---------------------------------- 
 f.   Place of                        London Stock Exchange 
       the transaction 
---  ------------------------------  ---------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBDLFFQFFXFBD

(END) Dow Jones Newswires

November 17, 2016 05:39 ET (10:39 GMT)